Investors in AMTZ assured of support

New MD extends open invitation to manufacturers of medical devices

September 12, 2019 12:57 am | Updated 12:57 am IST - VISAKHAPATNAM

Senior IAS officer Kartikeya Misra assumed charge as Managing Director and CEO of AP MedTech Zone on Wednesday.

After taking charge, Mr. Misra stressed that the government was committed to developing frugal and innovative technologies in the manufacturing of medical devices at AMTZ.

“All support will be extended to investors, both current as well as those who are looking forward to invest in this zone,” Mr. Misra said.

‘Proactive government’

“This government is proactive and assures that AMTZ will be transformed into one of the best scientific facilities, becoming a beacon for medical device manufacturing in the country,” he added.

The current focus would be on fast-tracking the completion of 18 labs which were the heart of this project to facilitate testing of medical devices at the earliest.

Mr. Misra later interacted with various stakeholders including manufacturers in the zone and assured them of continued support of the State Government.

Stock-taking meet

He also called for a meeting with various department heads in APMZ and Kalam Institute of Health Technology to understand the roles performed by various teams and asked them to bring any issues that they are facing to the management’s notice.

Mr. Misra extended an open invitation to all the investors and manufacturers of medical devices to utilise various opportunities available in the zone.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.